GB Patent

GB2142234A — Pharmaceutical dermal compositions with prolonged and continuous action based on essential fatty acids

Assigned to Individual · Expires 1985-01-16 · 41y expired

What this patent protects

Patent listed against dalbavancin-hydrochloride.

Drugs covered by this patent

dalbavancin-hydrochloride (DALBAVANCIN HYDROCHLORIDE)

Patent Metadata

Patent number: GB2142234A
Jurisdiction: GB
Classification: —
Expires: 1985-01-16
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.